NEW YORK, January 7, 2013 /PRNewswire/ --
PremierEquityReports.com provides investors with quality research and analysis on U.S. equities on the move and today issues a report on: Medi Swipe, Inc. (OTCBB: MWIP), New Western Energy, Inc. (OTCBB: NWTR), Titan Pharmaceuticals, Inc. (OTCBB: TTNP), and Advanced Cell Technology, Inc. (OTCBB: ACTC).
Medi Swipe, Inc. (OTCBB: MWIP) has recently announced a new corporate headquarters in Birmingham, Michigan. The Company made the decision to move from South Florida based on recent and favorable state legislation regarding medical marijuana and dispensary laws. Medi Swipe, Inc. hit a new all-time high of $0.035 on January 4, 2013. Medi Swipe, Inc. has gained nearly 135% so far in the month of January.
Read the entire press release issued by Medi Swipe, Inc. (OTCBB: MWIP) here: http://finance.yahoo.com/news/mediswipe-inc-announces-corporate-headquarters-145039811.html
New Western Energy Corp. (OTCBB: NWTR) has recently completed the acquisition of 8 property leases totaling 1,520 acres and 106 oil wells in Roger County, Oklahoma, from Pioneer Oil Development LLC. New Western Energy intends to provide the development funds necessary to bring in to production the existing wells, as well as the drilling of additional wells upon completion of the work overs. Within the acquired leases is 950 contiguous acres of which a full 640 acre section has open drilling opportunities of multiple proven oil and gas formations.
President and CEO, Javan Khazali, stated, "We are continuing to execute on our strategy of aggressively acquiring performing assets that are underdeveloped and will drive our growth in production." New Western Energy hit a new all-time high of $1.13 on January 3, 2013.
Read the entire press release issued by New Western Energy Corp. (OTCBB: NWTR) here: http://finance.yahoo.com/news/western-energy-corp-completes-acquisition-140000746.html
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) recently announced that the New Drug Application (NDA) for Probuphine® has been accepted for review and granted Priority Review designation by the U.S. Food and Drug Administration (FDA). Probuphine® is a novel, sub dermal implant and the first long-acting product designed to deliver six months of the drug buprenorphine hydrochloride following a single treatment. Titan Pharmaceuticals submitted the NDA for the maintenance treatment of opioid dependence in adult patients in October 2012 under Section 505(b)(2) of the Food, Drug and Cosmetic Act and referenced the approved sublingual tablet formulations of buprenorphine.
Titan Pharmaceuticals, Inc. has gained nearly 31% so far in the month of January.
Read the entire press release issued by Titan Pharmaceuticals, Inc. (OTCBB: TTNP) here: http://finance.yahoo.com/news/probuphine-r-receives-fda-priority-120000404.html
Advanced Cell Technology, Inc. (OTCBB: ACTC) recently appeared in the 'Christmas and New Year Special' issue of New Scientist. Advanced Cell Technology's iPS cell-driven human platelet program has been named as one of the "10 Ideas That Will Shape the Year," by the magazine. New Scientist is widely considered to be one of the most influential science and technology news magazines in the world.
"Human iPS cells are a game-changer in medicine," said Robert Lanza, M.D., chief scientific officer of Advanced Cell Technology. "They offer the possibility to generate a non-controversial, unlimited source of patient-specific stem cells without embryo destruction…We hope to initiate the first clinical trial using these promising cells in 2013."
Advanced Cell Technology, Inc. has gained nearly 44% so far in the month of January.
Read the entire press release issued by Advanced Cell Technology, Inc. (OTCBB: ACTC) here: http://finance.yahoo.com/news/scientist-magazine-selects-act-induced-133000152.html
Sign up to receive detailed reports and stock picks at http://www.PremierEquityReports.com. For real-time trade updates, follow our award winning hedge fund trader on Twitter @StockBrainiac. Premier Equity Reports also offers a FREE text message alert service to ensure that you receive all alerts. Simply text "reports" to 63566.
Premier Equity Reports is the U.S. leader in equity reports, offering quality reports to investors looking for the most undervalued companies in the market. Premier Equity Reports provides its subscribers with timely information and exclusive analysis on U.S. companies with substantial upside potential. Premier Equity Reports is the #1 free financial newsletter in the industry. Sign up now and see why thousands have joined already.
Disclosure: PremierEquityReports.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Premier Equity Reports is a wholly owned entity of Equities Awareness Group LLC. Equities Awareness Group LLC has been compensated up to fifty thousand dollars for marketing awareness on New Western Energy Corp. Please read our report and visit our website, for complete risks and disclosures.
Third Party Publishing Provider: FNNewswire, a FN Media Group, LLC Company.
SOURCE Equities Awareness Group